Biosimilar infliximab is effective and safe in inflammatory bowel disease patients naive to anti-TNF therapy: a tertiary center experience

Pathway
IBD

Conference
UEG Week 2016


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing